Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-09 4:30 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.7% | 1,000,000 (New Position) | View |
| 2021-03-02 4:32 pm Purchase | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA CAPITAL MANAGEMENT L.P. | 5,914,252 18.8% | 1,232,394 (+26.32%) | View |
| 2021-02-19 4:30 pm Purchase | 13D | VOR BIOPHARMA INC.COM VOR | RA CAPITAL MANAGEMENT L.P. | 11,120,973 30% | 11,120,973 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | RA CAPITAL MANAGEMENT L.P. | 0 0% | -761,666 (Position Closed) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 12,315,213 12.6% | 1,950,555 (+18.82%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | NOVAVAX INC NVAX | RA CAPITAL MANAGEMENT L.P. | 3,788,564 6% | 3,788,564 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | PREVAIL THERAPEUTICS INC PRVL | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,363,605 (Position Closed) | View |
| 2021-02-16 4:39 pm Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 4,179,067 9.5% | -1,243,245 (-22.93%) | View |
| 2021-02-16 4:39 pm Sale | 13G | VERASTEM, INC. VSTM | RA CAPITAL MANAGEMENT L.P. | 0 0% | -9,129,251 (Position Closed) | View |
| 2021-02-16 4:39 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 4,557,867 8.9% | 4,557,867 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | RA CAPITAL MANAGEMENT L.P. | 5,368,451 6.5% | 5,368,451 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | CURIS INC CRIS | RA CAPITAL MANAGEMENT L.P. | 7,707,790 8.5% | 7,707,790 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | CONCERT PHARMACEUTICALS INC CO CNCE | RA CAPITAL MANAGEMENT L.P. | 1,823,520 5.9% | 1,823,520 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | RA CAPITAL MANAGEMENT L.P. | 1,748,021 9.9% | 99,536 (+6.04%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 5,865,338 10.9% | 46,476 (+0.80%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | BCTG ACQUISITION CORP COM BCTG | RA CAPITAL MANAGEMENT L.P. | 1,250,000 5.8% | 1,250,000 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | DYNE THERAPEUTICS INC DYN | RA CAPITAL MANAGEMENT L.P. | 2,805,045 6.2% | 2,805,045 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | RA CAPITAL MANAGEMENT L.P. | 9,502,383 9.7% | 9,502,383 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | FRAZIER LIFESCIENCES ACQ CORP FLAC | RA CAPITAL MANAGEMENT L.P. | 1,000,000 7% | 1,000,000 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | GERON CORP GERN | RA CAPITAL MANAGEMENT L.P. | 31,114,941 9.99% | 31,114,941 (New Position) | View |